| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-05 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.29 | 0.0003 |